Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Journal of Gastrointestinal Surgery
Published in: Journal of Gastrointestinal Surgery 3/2015

01-03-2015 | Original Article

Robotic Versus Laparoscopic Total Mesorectal Excision for Rectal Cancer: a Meta-analysis of Eight Studies

Authors: Binghong Xiong, Li Ma, Wei Huang, Qikang Zhao, Yong Cheng, Jingshan Liu

Published in: Journal of Gastrointestinal Surgery | Issue 3/2015

Login to get access

Abstract

Background

Robotic surgery has been used successfully in many branches of surgery, but there is little evidence in the literature on its use in rectal cancer (RC). We conducted this meta-analysis of randomized controlled trials (RCTs) and non-randomized controlled trials (NRCTs) to evaluate whether the safety and efficacy of robotic total mesorectal excision (RTME) in patients with RC are equivalent to those of laparoscopic TME (LTME).

Methods

Pubmed, Embase, Cochrane Library, Ovid, and Web of Science databases were searched. Studies clearly documenting a comparison of RTME with LTME for RC were selected. Operative and recovery outcomes, early postoperative morbidity, and oncological parameters were evaluated.

Results

Eight studies were identified that included 1229 patients in total, 554 (45.08 %) in the RTME group and 675 (54.92 %) in the LTME group. Compared with LTME, RTME was associated with lower conversion rate (OR 0.23, 95 % CI [0.10, 0.52]; P = 0.0004), lower positive rate of circumferential resection margins (CRM) (2.74 % vs 5.78 %, OR 0.44, 95 % CI [0.20, 0.96], P = 0.04), and lesser incidence of erectile dysfunction (ED) (OR 0.09, 95 % CI [0.02, 0.41]; P = 0.002). Operation time, estimated blood loss, recovery outcome, postoperative morbidity and mortality, length of hospital stay, number of lymph nodes harvested, distal resection margin (DRM), proximal resection margin (PRM), and local recurrence had no significant differences between the two groups.

Conclusions

RTME is safe and feasible and may be an alternative treatment for RC. More international multicenter prospective large sample RCTs investigating the long-term oncological and functional outcomes are needed to determine the advantages of RTME over LTME in RC.
Literature
1.
Clinical Outcomes of Surgical Therapy Study Group. A comparison of laparoscopically assisted and open colectomy for colon cancer. N Engl J Med .2004;350:2050–9.CrossRef
2.
Veldkamp R, Kuhry E, Hop WC, Jeekel J, Kazemier G, Bonjer HJ, et al. Laparoscopic surgery vs. open surgery for colon cancer: shortterm outcomes of a randomised trial. Lancet Oncol.2005;6:477–84.CrossRefPubMed
3.
Guillou PJ, Quirke P, Thorpe H, Walker J, Jayne DG, Smith AM, et al. Short-term endpoints of conventional vs. laparoscopic assisted surgery in patients with colorectal cancer (MRCCLASSIC trial): multicenter, randomised controlled trial. Lancet.2005;365:1718–26.CrossRefPubMed
4.
Schwab KE, Dowson HM, Van Dellen J, et al. The uptake of laparoscopic colorectal surgery in Great Britain and Ireland: a questionnaire survey of consultant members of the ACPGBI. Colorectal Dis. 2009; 11:318–322.CrossRefPubMed
5.
Heald RJ, Husband EM, Ryall RD. The mesorectum in rectal cancer surgery—the clue to pelvic recurrence? Br J Surg 1982;69:613–6.CrossRefPubMed
6.
Bärlehner E, Benhidjeb T, Anders S, Schicke B. Laparoscopic resection for rectal cancer: outcomes in 194 patients and review of the literature. Surg Endosc 2005;19:757–766CrossRefPubMed
7.
Bretagnol F, Lelong B, Laurent C, Moutardier V, Rullier A, Monges G, Delpero JR, Rullier E. The oncological safety of laparoscopic total mesorectal excision with sphincter preservation for rectal carcinoma. Surg Endosc 19:892–896
8.
Jayne DG, Guillou PJ, Thorpe H, Quirke P, Copeland J, Smith AM, Heath RM, Brown JM; UK MRC CLASICC Trial Group. Randomized trial of laparoscopic-assisted resection of colorectal carcinoma:3-year results of the UK MRC CLASICC Trial Group. J Clin Oncol 2007;25(21):3061–3068.CrossRefPubMed
9.
Leroy J, Jamali F, Forbes L, Smith M, Rubino F, Mutter D, Marescaux J. Laparoscopic total mesorectal excision (TME) for rectal cancer surgery: long-term outcomes. Surg Endosc 2004;18:281–289CrossRefPubMed
10.
Morino M, Allaix ME, Giraudo G, Corno F, Garrone C. Laparoscopic versus open surgery for extraperitoneal rectal cancer: a prospective comparative study. Surg Endosc 2005;19:1460–1467CrossRefPubMed
11.
Kang SB, Park JW, Jeong SY, Nam BH, Choi HS, Kim DW, et al.Open versus laparoscopic surgery for mid or low rectal cancer after neoadjuvant chemoradiotherapy (COREAN trial): short-term outcomes of an open-label randomised controlled trial. Lancet Oncol 2010;11:637–645CrossRefPubMed
12.
Zhou ZG, Hu M, Li Y, Lei WZ, Yu YY, Cheng Z, et al. Laparoscopic versus open total mesorectal excision with anal sphincter preservation for low rectal cancer. Surg Endosc 2004;18:1211–1215CrossRefPubMed
13.
Arezzo A, Passera R, Scozzari G, Verra M, Morino M. Laparoscopy for rectal cancer reduces short-term mortality and morbidity: results of a systematic review and meta-analysis. Surg Endosc. 2013;27(5):1485–502.CrossRefPubMed
14.
Ahmad NZ, Racheva G, Elmusharaf H. A systematic review and meta-analysis of randomized and non-randomized studies comparing laparoscopic and open abdominoperineal resection for rectal cancer. Colorectal Dis. 2013;15(3):269–77.CrossRefPubMed
15.
Xiong B, Ma L, Zhang C. Laparoscopic versus open total mesorectal excision for middle and low rectal cancer: a meta-analysis of results of randomized controlled trials. J Laparoendosc Adv Surg Tech A. 2012;22(7):674–84.CrossRefPubMed
16.
Trastulli S, Cirocchi R, Listorti C, Cavaliere D, Avenia N, Gullà N, Giustozzi G, Sciannameo F, Noya G, Boselli C. Laparoscopic vs open resection for rectal cancer: a meta-analysis of randomized clinical trials. Colorectal Dis.2012;14(6):e277-96.CrossRefPubMed
17.
Ohtani H, Tamamori Y, Azuma T, Mori Y, Nishiguchi Y, Maeda K, Hirakawa K. Ameta-analysis of the short- and long-term results of randomized controlled trials that compared laparoscopy-assisted and conventional open surgery for rectal cancer. J Gastrointest Surg. 2011;15(8):1375–85.CrossRefPubMed
18.
Huang MJ, Liang JL, Wang H, Kang L, Deng YH, Wang JP. Laparoscopic-assisted versus open surgery for rectal cancer: a meta-analysis of randomized controlled trials on oncologic adequacy of resection and long-term oncologic outcomes. Int J Colorectal Dis. 2011;26(4):415–21.CrossRefPubMed
19.
Gao F, Cao YF, Chen LS. Meta-analysis of short-term outcomes after laparoscopic resection for rectal cancer. Int J Colorectal Dis. 2006;21(7):652–6.CrossRefPubMed
20.
Aziz O, Constantinides V, Tekkis PP, Athanasiou T, Purkayastha S, Paraskeva P, Darzi AW, Heriot AG. Laparoscopic versus open surgery for rectal cancer: a meta-analysis. Ann Surg Oncol. 2006;13(3):413–24.CrossRefPubMed
21.
Wexner SD, Bergamaschi R, Lacy A, Udo J, Bro¨lmann H, Kennedy RH, John H. The current status of robotic pelvic surgery: results of a multinational interdisciplinary consensus conference. Surg Endosc 2009;23:438–443CrossRefPubMed
22.
Pigazzi A, Ellenhorn JD, Ballantyne GH, Paz IB .Robotic assisted laparoscopic low anterior resection with total mesorectal excision for rectal cancer. Surg Endosc 2006; 20:1521–1525CrossRefPubMed
23.
Xiong BH, Ma L, Zhang CQ. Robotic versus laparoscopic gastrectomy for gastric cancer: a meta-analysis of short outcomes. Surg Oncol . 2012;21(4):274–80.CrossRefPubMed
24.
Stroup DF, Berlin JA, Morton SC, et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Metaanalysis of Observational Studies in Epidemiology (MOOSE) group. JAMA. 2000;283: 2008–12.CrossRefPubMed
25.
26.
27.
28.
29.
Baik SH, Ko YT, Kang CM, et al. Robotic tumor-specific mesorectal excision of rectal cancer: short-term outcome of a pilot randomized trial. Surg Endosc. 2008;22:1601–8.CrossRefPubMed
30.
Baik SH, Kwon HY, Kim JS, et al. Robotic versus laparoscopic low anterior resection of rectal cancer: short-term outcome of a prospective comparative study. Ann Surg Oncol. 2009;16: 1480–7CrossRefPubMed
31.
Kim NK, Kang J. Optimal Total Mesorectal Excision for Rectal Cancer: the Role of Robotic Surgery from an Expert’s View. J Korean Soc Coloproctol. 2010;26(6):377–87.CrossRefPubMedCentralPubMed
32.
Kim JY, Kim NK, Lee KY, Hur H, Min BS, Kim JH. A comparative study of voiding and sexual function after total mesorectal excision with autonomic nerve preservation for rectal cancer: laparoscopic versus robotic surgery. Ann Surg Oncol.2012;19(8):2485–93.CrossRefPubMed
33.
Kim YW, Lee HM, Kim NK, Min BS, Lee KY. The learning curve for robot-assisted total mesorectal excision for rectal cancer. Surg Laparosc Endosc Percutan Tech. 2012;22(5):400–5.CrossRefPubMed
34.
Baek SJ, Al-Asari S, Jeong DH, Hur H, Min BS, Baik SH, Kim NK. Robotic versus laparoscopic coloanal anastomosis with or without intersphincteric resection for rectal cancer. Surg Endosc. 2013 May 25. [Epub ahead of print]
35.
Kang J, Yoon KJ, Min BS, Hur H, Baik SH, Kim NK, Lee KY. The impact of robotic surgery for mid and low rectal cancer: a case-matched analysis of a 3-arm comparison—open, laparoscopic, and robotic surgery. Ann Surg. 2013;257(1):95–101.CrossRefPubMed
36.
Park JS, Choi GS, Lim KH, Jang YS, Jun SH. Robotic-assisted versus laparoscopic surgery for low rectal cancer: case-matched analysis of short-term outcomes. Ann Surg Oncol. 2010;17(12):3195–202.CrossRefPubMed
37.
Park SY, Choi GS, Park JS, Kim HJ, Ryuk JP. Short-term clinical outcome of robot-assisted intersphincteric resection for low rectal cancer: a retrospective comparison with conventional laparoscopy. Surg Endosc. 2013;27(1):48–55.CrossRefPubMed
38.
Park JS, Choi GS, Lim KH, et al. S052: a comparison of robot assisted, laparoscopic, and open surgery in the treatment of rectal cancer. Surg Endosc. 2011;25:240–8.CrossRefPubMed
39.
Kwak JM, Kim SH, Kim J, Son DN, Baek SJ, Cho JS. Robotic vs laparoscopic resection of rectal cancer: short-term outcomes of a case-control study. Dis Colon Rectum. 2011;54(2):151–6.CrossRefPubMed
40.
Baek SJ, Kim SH, Cho JS, Shin JW, Kim J. Robotic versus conventional laparoscopic surgery for rectal cancer: a cost analysis from a single institute in Korea. World J Surg. 2012;36(11):2722–9CrossRefPubMed
41.
Baek JH, Pastor C, Pigazzi A. Robotic and laparoscopic total mesorectal excision for rectal cancer: a case-matched study. Surg Endosc. 2011;25:521–5.CrossRefPubMed
42.
Patriti A, Ceccarelli G, Bartoli A, Spaziani A, Biancafarina A, Casciola L. Short- and medium-term outcome of robot-assisted and traditional laparoscopic rectal resection. JSLS 2009; 13: 176–183PubMedCentralPubMed
43.
Bianchi PP, Ceriani C, Locatelli A, Spinoglio G, Zampino MG, Sonzogni A, Crosta C, Andreoni B. Robotic versus laparoscopic total mesorectal excision for rectal cancer: a comparative analysis of oncological safety and short-term outcomes. Surg Endosc 2010; 24: 2888–2894CrossRefPubMed
44.
Popescu I, Vasilescu C, Tomulescu V, Vasile S, Sgarbura O. The minimally invasive approach, laparoscopic and robotic, in rectal resection for cancer. A single center experience. Acta Chir Iugosl 2010; 57: 29–35CrossRefPubMed
45.
D’Annibale A, Pernazza G, Monsellato I, Pende V, Lucandri G, Mazzocchi P, Alfano G.Total mesorectal excision: a comparison of oncological and functional outcomes between robotic and laparoscopic surgery for rectal cancer. Surg Endosc. 2013;27(6):1887–95.CrossRefPubMed
46.
Weber PA, Merola S, Wasielewski A, Ballantyne GH.Telerobotic-assisted laparoscopic right and sigmoid colectomies for benign disease. Dis Colon Rectum 2002; 45: 1689–94CrossRefPubMed
47.
48.
Hellan M, Anderson C, Ellenhorn JD, Paz B, Pigazzi A. Shortterm outcomes after robotic-assisted total mesorectal excision for rectal cancer. Ann Surg Oncol. 2007;14:3168–3173.CrossRefPubMed
49.
Balch GC, De Meo A, Guillem JG. Modern management of rectal cancer: a 2006 update. World J Gastroenterol 2006;12: 3186–3195PubMedCentralPubMed
50.
Chessin DB, Guillem JG. Surgical issues in rectal cancer: a 2004 update. Clin Colorectal Cancer 2004;4:233–240CrossRefPubMed
51.
Compton CC, Fielding LP, Burgart LJ, Conley B, Cooper HS, Hamilton SR, et al. Prognostic factors in colorectal cancer. College of American Pathologists Consensus Statement 1999. Arch Pathol Lab Med 2000;124:979–94.PubMed
52.
Nagtegaal ID, van de Velde CJ, van der Worp E, Kapiteijn E, Quirke P, van Krieken JH. Macroscopic evaluation of rectal cancer resection specimen: clinical significance of the pathologist in quality control. J Clin Oncol 2002; 20:1729–1734CrossRefPubMed
53.
Wasserberg N, Gutman H. Resection margins in modern rectal cancer surgery. J Surg Oncol 2008;98:611–615CrossRefPubMed
54.
Quirke P, Durdey P, Dixon MF, Williams NS. Local recurrence of rectal adenocarcinoma due to inadequate surgical resection: histopathological study of lateral tumour spread and surgical excision. Lancet 1986;2:996–999CrossRefPubMed
55.
Park IJ, Kim JC.Adequate length of the distal resection margin in rectal cancer: from the oncological point of view.J Gastrointest Surg 2010; 14:1331–1337CrossRefPubMed
56.
Tilney HS, Rasheed S, Northover JM, Tekkis PP .The influence of circumferential resection margins on long-term outcomes following rectal cancer surgery. Dis Colon Rectum 2009; 52:1723–1729CrossRefPubMed
57.
Hermanek P, Junginger T. The circumferential resection margin in rectal carcinoma surgery. Tech Coloproctol 2005;9:193–199CrossRefPubMed
58.
Nagtegaal ID, van Krieken JHJM. The role of pathologists in the quality control of diagnosis and treatment of rectal cancer—an overview. Eur J Cancer 2002; 38:964–972CrossRefPubMed
59.
Nagtegaal ID, Marijnen CA, Kranenbarg EK, van de Velde CJ, van Krieken JH. Circumferential margin involvement is still an important predictor of local recurrence in rectal carcinoma: not one millimeter but two millimeters is the limit. Am J Surg Pathol 2002;26:350–357CrossRefPubMed
60.
Shirouzu K, Isomoto H, Kakegawa T. Distal spread of rectal cancer and optimal distal margin of resection for sphincter preserving surgery. Cancer 1995; 76:388–392CrossRefPubMed
61.
Vernava AM 3rd, Moran M, Rothenberger DA, Wong WD.A prospective evaluation of distal margins in carcinoma of the rectum. Surg Gynecol Obstet 1992; 175:333–336PubMed
62.
MacLehose RR, Reeves BC, Harvey IM, Sheldon TA, Russell IT, Black AM. A systematic review of comparisons of effect sizes derived from randomised and non-randomised studies. Health Technol Assess 2000;4:1–154.PubMed
63.
Abraham NS, Byrne CJ, Young JM, Solomon MJ. Meta-analysis of well-designed nonrandomized comparative studies of surgical procedures is as good as randomized controlled trials. J Clin Epidemiol 2010;63:238–245.CrossRefPubMed
64.
Collinson FJ, Jayne DG, Pigazzi A, Tsang C, Barrie JM, Edlin R, Garbett C, Guillou P, Holloway I, Howard H, Marshall H, McCabe C, Pavitt S, Quirke P, Rivers CS, Brown JM. An international, multicentre, prospective, randomised, controlled, unblinded, parallel-group trial of robotic-assisted versus standard laparoscopic surgery for the curative treatment of rectal cancer. Int J Colorectal Dis. 2012;27:233–41.CrossRefPubMed
Metadata
Title
Robotic Versus Laparoscopic Total Mesorectal Excision for Rectal Cancer: a Meta-analysis of Eight Studies
Authors
Binghong Xiong
Li Ma
Wei Huang
Qikang Zhao
Yong Cheng
Jingshan Liu
Publication date
01-03-2015
Publisher
Springer US
Published in
Journal of Gastrointestinal Surgery / Issue 3/2015
Print ISSN: 1091-255X
Electronic ISSN: 1873-4626
DOI
https://doi.org/10.1007/s11605-014-2697-8

Other articles of this Issue 3/2015

Journal of Gastrointestinal Surgery 3/2015 Go to the issue

Evidence-Based Current Surgical Practice

Current Status of Management of Malignant Disease: What Are the Options for Premalignant Lesions of the Esophagus and Stomach?

How I do it

How I Do It: Martius Flap for Rectovaginal Fistulas

Original Article

Quantifying the Burden of Complications Following Total Pancreatectomy Using the Postoperative Morbidity Index: A Multi-Institutional Perspective

Original Article

Role of Antibiotic Prophylaxis in Necrotizing Pancreatitis: A Meta-Analysis

2014 SSAT State of the Art Conference

2014 SSAT State-of-the-Art Conference: Advances in Diagnosis and Management of Gastroesophageal Reflux Disease

2014 SSAT Poster Presentation

Perioperative and Long-Term Outcome after Standard Pancreaticoduodenectomy, Additional Portal Vein and Multivisceral Resection for Pancreatic Head Cancer